Cargando…

209 Seroprevalence of Anti-SARS CoV-2 Nucleocapsid IgG in a Cohort of Healthcare Workers Over Nine Months

Detalles Bibliográficos
Autores principales:	The CONSERVE-HCW Research Group, Tiffany, B., Bremner, R., Cogo, J., Zumbuhl, J., Wood, L., Arriola, B., Wiley, N., Sanders, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2021
Materias:	Research Forum Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536272/ http://dx.doi.org/10.1016/j.annemergmed.2021.09.221

Ejemplares similares

32 Decay of Anti-SARS-CoV-2 Nucleocapsid IgG in Seropositive Health Care Workers Over Time
por: Tiffany, B., et al.
Publicado: (2021)

Seroprevalence of IgG and Subclasses against the Nucleocapsid of SARS-CoV-2 in Health Workers
por: Cortés-Sarabia, Karen, et al.
Publicado: (2023)

The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021)

Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India
por: Lone, Kouser Sideeq, et al.
Publicado: (2022)

58: Seroprevalence of COVID-19 IgG in the cystic fibrosis population
por: Mahan, K., et al.
Publicado: (2021)

Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021)

Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population
por: Yusoff, Ahmad Faudzi, et al.
Publicado: (2021)

Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients
por: Movsisyan, Mariam, et al.
Publicado: (2022)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Kinetics of IgG antibody to cytomegalovirus (CMV) after birth and seroprevalence of anti-CMV IgG in Chinese children
por: Chen, Jie, et al.
Publicado: (2012)

Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
por: Tsai, Jih-Jin, et al.
Publicado: (2023)

The seroprevalence of Mycoplasma pneumoniae IgM and IgG antibodies in patients with ischemic stroke
por: Roham, Maryam, et al.
Publicado: (2016)

Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding—Who Is Binding Who and Why?
por: Iles, Jason K., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023
por: Chansaenroj, Jira, et al.
Publicado: (2023)

IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays
por: Shah, Jyotsna, et al.
Publicado: (2021)

Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity
por: Nückel, Julius, et al.
Publicado: (2022)

Seroprevalence of Rubella IgG Antibody in Pregnant Women in Osogbo, Nigeria
por: Kolawole, Olatunji Mathew, et al.
Publicado: (2014)

Correction to: Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
por: Tsai, Jih-Jin, et al.
Publicado: (2023)

Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study
por: Maina, Daniel, et al.
Publicado: (2022)

Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey
por: Ibrahim, Saira, et al.
Publicado: (2016)

The salinity challenge
por: Sanders, Dale
Publicado: (2020)

Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS
por: Saijo, Masayuki, et al.
Publicado: (2005)

Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland
por: Zasada, Aleksandra A, et al.
Publicado: (2013)

Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants
por: Cho, Hye-Kyung, et al.
Publicado: (2016)

Determination of Seroprevalence of Borrelia burgdorferi IgG in Adult Population Living in Trabzon
por: Cora, Merve, et al.
Publicado: (2017)

Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka
por: Senanayake, Bimsara, et al.
Publicado: (2019)

Seroprevalence of Aspergillus-Specific IgG Antibody among Mozambican Tuberculosis Patients
por: Salzer, Helmut J. F., et al.
Publicado: (2021)

74 Patient Perceptions of Drive Through Medical Treatment Facilities During the COVID-19 Pandemic
por: Combat Trauma Research Group, et al.
Publicado: (2021)

Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19–recovered patients who received a kidney transplant
por: Chang, Chih-Chao, et al.
Publicado: (2021)

Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2
por: Liu, Pan-pan, et al.
Publicado: (2021)

IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases
por: Tutukina, Maria, et al.
Publicado: (2021)

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

An Electrochemical Immunosensor Based on Carboxylated Graphene/SPCE for IgG-SARS-CoV-2 Nucleocapsid Determination
por: de Souza Freire, Luciana, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
por: Borges, Lysandro Pinto, et al.
Publicado: (2020)

Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis
por: Weissbrich, Benedikt, et al.
Publicado: (2007)

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis
por: Golden, Allison, et al.
Publicado: (2016)

Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results
por: Wang, Hannah, et al.
Publicado: (2021)

Seroprevalence of IgM and IgG anti-SARS-COV-2 and associated factors among agricultural workers in Colombia
por: Rodríguez, M.F., et al.
Publicado: (2022)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v20k62l97me0ai8sj7l5ki03ag